http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients' lymphoma can be eradicated as they prepare for bone marrow transplant, say researchers at the 2013 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging. In a study presented at the meeting, survival rates without recurrence improved with the addition of RIT, with some having a 100 percent chance of survival over two years. http://medicalxpress.com/news/2013-06-radioimmunotherapy-advanced-lymphoma-patients.html Cancer Tue, 11 Jun 2013 09:11:34 EST news290160619 (HealthDay)—For elderly patients with metastatic colorectal cancer (mCRC), scores on the Mini-Mental State Examination (MMSE) and Instrumental Activities of Daily Living (IADL) were predictive of severe toxicity or unexpected hospitalization after fluorouracil-based chemotherapy with or without irinotecan (IRI), according to research published online March 4 in the Journal of Clinical Oncology. http://medicalxpress.com/news/2013-03-geriatric-factors-tolerances-chemotherapy.html Cancer Thu, 14 Mar 2013 14:03:10 EST news282488570 Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments. http://medicalxpress.com/news/2013-03-breakthrough-leukemia.html Cancer Wed, 13 Mar 2013 10:13:54 EST news282388426 A new drug for patients with acute myeloid leukemia (AML) marked by a specific type of genetic mutation has shown surprising promise in a Phase II clinical trial. In more than a third of participants, the leukemia was completely cleared from the bone marrow, and as a result, many of these patients were able to undergo potentially curative bone marrow transplants, according to investigators at the Johns Hopkins Kimmel Cancer Center and nine other academic medical centers around the world. Many of the participants who did well with the new drug, quizartinib or AC220, had failed to respond to prior therapies. http://medicalxpress.com/news/2012-12-high-risk-leukemia-patients-experimental-drug.html Medications Sun, 09 Dec 2012 11:30:01 EST news274274411 A multicenter trial showed that nearly half of young patients with early-stage Hodgkin lymphoma can be cured without undergoing either irradiation or intensive chemotherapy that would leave them at risk for second cancers, infertility, heart and other problems later. http://medicalxpress.com/news/2012-06-quest-treatment-pediatric-hodgkin-lymphoma.html Cancer Tue, 26 Jun 2012 16:00:07 EST news259940424 Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years later, compared with patients given standard chemotherapy treatment plus rituximab, according to an article published Online First in the Lancet. http://medicalxpress.com/news/2011-11-intensive-chemotherapy-recurrence-survival-younger.html Cancer Thu, 24 Nov 2011 18:30:03 EST news241362774 Monika McBride has acute myeloid leukemia, a life-threatening blood cancer that requires six months of intensive chemotherapy. Three days before her third treatment, however, a nurse called to cancel her appointment: Her doctor had run out of the drug. http://medicalxpress.com/news/2011-08-drug-short-endangering-patients.html Medications Fri, 19 Aug 2011 10:40:01 EST news232968023 Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients treated at St. Jude Children's Research Hospital, with patients who lacked genetically matched donors recording the most significant gains. The results are believed to be the best ever reported for leukemia patients who underwent bone marrow transplantation. http://medicalxpress.com/news/2011-07-bone-marrow-transplant-survival-young.html Medical research Thu, 14 Jul 2011 11:30:01 EST news229860377 (Medical Xpress) -- Researchers at the Duke Cancer Institute and the University of Chicago have found a way to identify the one in four patients with recurring head and neck cancers who are most likely to benefit from a second round of chemotherapy and radiation. http://medicalxpress.com/news/2011-06-criteria-treatment-success-recurring-neck.html Cancer Mon, 13 Jun 2011 08:23:13 EST news227171928